🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07094100
Recruiting Not applicable

Tissue Engineered Cartilage to Repairing Articular Cartilage Defects

NCT07094100 · tracked via the Priya Life Science China tracker
Sponsor
The First Affiliated Hospital of Xinxiang Medical College
Phase
Not applicable
Started
2026-04-20
Last updated
2026-05-04

Condition(s) studied

Cartilage InjuryOA Knee

Investigational drug(s) / intervention(s)

Tissue engineered cartilage

Tissue engineered cartilage: Cartilage constructed by autologous bone marrow mesenchymal stem cells

Study summary

The joint cartilage constructed by combining bone marrow mesenchymal stem cells with three-dimensional materials has achieved the goal of repairing joint cartilage.

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
No
Inclusion Criteria: 1. The patients' age ranges from 18 to 65 years old, and gender is not restricted; 2. The imaging results show that the epiphyseal growth is mature; 3. The defects or localized injuries of joint cartilage caused by trauma or other reasons; 4. The injured area is the distal weight-bearing surface of the femoral condyle of the knee joint, with no more than 4 lesions, and there is no injury to the cruciate ligaments; 5. The patients voluntarily sign and provide a written informed consent form and are willing to closely cooperate with the doctor's strict postoperative rehabilitation program. Exclusion Criteria: 1. The patient is extremely overweight, with a body mass index greater than 35; 2. The lower limb alignment is valgus by more than 10° and varus by more than 5°; 3. Multiple ligament injuries; 4. There are numerous bad habits such as heavy smoking, drug abuse, and excessive alcohol consumption; 5. Has undergone open knee joint surgery within the past six months; 6. Has severe joint stiffness or fibrosis; 7. Has an allergic constitution or a history of allergic reactions to collagen; 8. Has mental abnormalities; 9. Cannot or is unwilling to undergo rehabilitation training; 10. Has primary cardiovascular diseases, lung diseases, endocrine and metabolic disorders, or other serious diseases that affect their daily life, such as tumors or AIDS; 11. Pregnant or lactating women, or those planning to conceive during the trial period; 12. Other acute or chronic diseases, for which the researchers consider surgery to be inappropriate.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
The First Affiliated Hospital of Xinxiang Medical College Xinxiang Henan Recruiting

More The First Affiliated Hospital of Xinxiang Medical College trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07094100 on ClinicalTrials.gov ↗ ← All trials in China